Comparison of clinical outcomes between 1st-line osimertinib, 1G/2G EGFR-TKIs followed by osimertinib and without osimertinib

Uehara, Y; Yoshida, T; Takeyasu, Y; Tateichi, A; Torasawa, M; Masuda, K; Shinno, Y; Matsumoto, Y; Okuma, Y; Goto, Y; Horinouchi, H; Yamamoto, N; Ohe, Y

ANNALS OF ONCOLOGY, 2023; 34 (): S1418

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索